Dovitinib

According to the NCI website, Dovitinib is an orally bioavailable lactate salt of a benzimidazole-quinolinone compound with potential antineoplastic activity. Check for active clinical trials using this agent.

More Information in English:

Link to Drug Information Portal, a service of the U.S. National Library of Medicine, National Institutes of Health

Link to National Cancer Institute

Tyrosin Kinase Inhibitor